Symbol="RNAZ"
AssetType="Common Stock"
Name="Transcode Therapeutics Inc"
Description="TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic diseases. The company is headquartered in Boston, Massachusetts."
CIK="1829635"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6 LIBERTY SQUARE, #2382, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2998900"
EBITDA="-19982780"
PERatio="None"
PEGRatio="None"
BookValue="-0.299"
DividendPerShare="0"
DividendYield="0"
EPS="-28.69"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.028"
ReturnOnEquityTTM="-2.256"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-28.69"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.719"
EVToRevenue="-"
EVToEBITDA="-0.527"
Beta="-0.596"
num_52WeekHigh="31"
num_52WeekLow="1.46"
num_50DayMovingAverage="2.502"
num_200DayMovingAverage="7.79"
SharesOutstanding="1801200"
DividendDate="None"
ExDividendDate="None"
symbol="RNAZ"
open="1.65"
high="1.68"
low="1.62"
price="1.67"
volume="20151.00"
latest_trading_day="2023-08-11"
previous_close="1.68"
change="-0.01"
change_percent="-0.8929%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="530488"
Change_recent_avg="-0.04"
Delta_recent_avg="0.19"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-1.66"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0043.jpeg"
image_negative_thumbnail_id_2="99"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_neutral_thumbnail_id_1="564"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="1016"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0178.jpeg"
image_positive_thumbnail_id_2="962"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
